<VariationArchive RecordType="classified" VariationID="981222" VariationName="NM_002890.3(RASA1):c.499del (p.Glu167fs)" VariationType="Deletion" Accession="VCV000981222" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-04-13" MostRecentSubmission="2021-04-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="969307" VariationID="981222">
      <GeneList>
        <Gene Symbol="RASA1" FullName="RAS p21 protein activator 1" GeneID="5921" HGNC_ID="HGNC:9871" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87267883" stop="87391916" display_start="87267883" display_stop="87391916" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86564069" stop="86687742" display_start="86564069" display_stop="86687742" Strand="+" />
          </Location>
          <OMIM>139150</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RASA1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RASA1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002890.3(RASA1):c.499del (p.Glu167fs)</Name>
      <CanonicalSPDI>NC_000005.10:87268948:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87268949" stop="87268949" display_start="87268949" display_stop="87268949" variantLength="1" positionVCF="87268948" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86564766" stop="86564766" display_start="86564766" display_stop="86564766" variantLength="1" positionVCF="86564765" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>E167fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.87268950del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.87268950del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.86564767del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.86564767del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011650.1" sequenceAccession="NG_011650" sequenceVersion="1" change="g.5617del">
            <Expression>NG_011650.1:g.5617del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002890.3" sequenceAccession="NM_002890" sequenceVersion="3" change="c.499del" MANESelect="true">
            <Expression>NM_002890.3:c.499del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002881.1" sequenceAccession="NP_002881" sequenceVersion="1" change="p.Glu167fs">
            <Expression>NP_002881.1:p.Glu167fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022650.3" sequenceAccession="NM_022650" sequenceVersion="3" change="c.-98del">
            <Expression>NM_022650.3:c.-98del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2112223281" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="protein truncation">
        <XRef ID="0015" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002890.3(RASA1):c.499del (p.Glu167fs) AND Capillary malformation-arteriovenous malformation 1" Accession="RCV001354043" Version="1">
        <ClassifiedConditionList TraitSetID="5197">
          <ClassifiedCondition DB="MedGen" ID="C4747394">Capillary malformation-arteriovenous malformation 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-04-13" MostRecentSubmission="2021-04-13">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5197" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="652" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation 1</ElementValue>
                <XRef ID="MONDO:0020783" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMAVM1</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMAVM</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</Attribute>
                <XRef ID="NBK52764" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9787" />
                <XRef ID="9787" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21348050</ID>
                <ID Source="BookShelf">NBK52764</ID>
              </Citation>
              <XRef ID="137667" DB="Orphanet" />
              <XRef ID="90307" DB="Orphanet" />
              <XRef ID="C4747394" DB="MedGen" />
              <XRef ID="MONDO:0020783" DB="MONDO" />
              <XRef Type="MIM" ID="608354" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2839249" SubmissionDate="2020-10-07" DateLastUpdated="2021-04-13" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="SUB8286328" submittedAssembly="hg19" title="SUB8286328" />
        <ClinVarAccession Accession="SCV001437513" DateUpdated="2021-04-13" DateCreated="2021-04-13" Type="SCV" Version="1" SubmitterName="Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Chulalongkorn University" OrgID="507783" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The variation is predicted to result in premature termination codon due to the frameshift changed by 1 bp deletion in RASA1. The mutation in this gene is known to be associated with capillary-malformation- arteriovenous malformation 1. The loss of function is the known mechanisms of this gene. The variant was not found in gnomAD database or TOPMED database. The clinical manifestation of the patient can be explained by the change in this gene. Therefore, we characterize this variant as pathogenic according to the ACMG criteria.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>Thai</Ethnicity>
              <GeographicOrigin>Thailand</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RASA1">
              <Name>RAS p21 protein activator 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <FunctionalConsequence Value="protein truncation">
            <XRef DB="Variation Ontology" ID="0015" URL="http://purl.obolibrary.org/obo/VariO_0015" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002890.2:c.499delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608354" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8286328</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2839249" TraitType="Disease" MappingType="XRef" MappingValue="608354" MappingRef="OMIM">
        <MedGen CUI="C4747394" Name="Capillary malformation-arteriovenous malformation 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

